Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pre-invasive ovarian mucinous tumors are characterized by CDKN2A and RAS pathway aberrations.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Oct 2012

Hunter Sally M, Gorringe Kylie L, Christie Michael, Rowley Simone M, Bowtell David D, Campbell Ian G

Abstract excerpt

INTRODUCTION: Mucinous tumors are the second most common form of epithelial ovarian tumor, yet the cell of origin for this histologic subtype remains undetermined. Although these tumors are thought to arise through a stepwise progression from benign cystadenoma to borderline tumor to invasive carcinoma, few studies have attempted to comprehensively characterize the genetic changes specific to this subtype or its...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Mucinous
Share to Cyclin-Dependent Kinase Inhibitor p16

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Copy Number Variations

Share to DNA Mutational Analysis

Share to Loss of Heterozygosity

Share to Neoplasm Staging

Share to Ovarian Neoplasms

Share to ras Proteins

Source

Identifiers

PMID: 22891197
DOI: 10.1158/1078-0432.CCR-12-1103

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pre-invasive ovarian mucinous tumors are characterized by CDKN2A and RAS pathway aberrations.PMID 22891197Read ↗

The molecular origin and taxonomy of mucinous ovarian carcinomaSemantic proximity Read ↗

Molecular Landscape of Borderline Ovarian Tumors: A Systematic ReviewSemantic proximity Read ↗

Molecular characterization of borderline and malignant Brenner tumors: implications for pathogenesis and therapeutics.Semantic proximity Read ↗

Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.Semantic proximity Read ↗

Molecular pathology of ovarian cancer.Semantic proximity Read ↗

Molecular pathology of epithelial ovarian cancer.Semantic proximity Read ↗

Origins and molecular pathology of ovarian cancer.Semantic proximity Read ↗

Copy number aberrations in benign serous ovarian tumors: a case for reclassification?Semantic proximity Read ↗

Endometrioid Versus Seromucinous Borderline Ovarian Tumors: Divergent Molecular Signatures and a Shared Role as Precursors to Endometrioid Carcinoma.Semantic proximity Read ↗

Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment.Semantic proximity Read ↗

Genetic and molecular changes in ovarian cancerSemantic proximity Read ↗

Ovarian carcinoma: pathology review with an emphasis in their molecular characteristicsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.